Pasar al contenido principal

DESCIFRANDO LOS SUBTIPOS DE MICROGLIA DELETEREA POTENCIALMENTE RELEVANTES EN ENFERMEDADES NEURODEGENERATIVAS

PID2021-124096OB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2021
Plan Estatal 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario UNIVERSIDAD DE SEVILLA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 9
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

APOE in the bullseye of neurodegenerative diseases: impact of the APOE genotype in Alzheimer's disease pathology and brain diseases

  • Fernández-Calle, Rosalía
  • Konings, Sabine C.
  • Frontiñán-Rubio, Javier
  • García-Revilla, Juan
  • Camprubí-Ferrer, Lluís
  • Svensson, Martina
  • Martinson, Isak
  • Boza-Serrano, Antonio
  • Venero, José L.
  • Nielsen, Henrietta M.
  • Gouras, Gunnar K.
  • Deierborg, Tomas
ApoE is the major lipid and cholesterol carrier in the CNS. There are three major human polymorphisms, apoE2, apoE3, and apoE4, and the genetic expression of APOE4 is one of the most influential risk factors for the development of late-onset Alzheimer's disease (AD). Neuroinflammation has become the third hallmark of AD, together with Amyloid-β plaques and neurofibrillary tangles of hyperphosphorylated aggregated tau protein. This review aims to broadly and extensively describe the differential aspects concerning apoE. Starting from the evolution of apoE to how APOE's single-nucleotide polymorphisms affect its structure, function, and involvement during health and disease. This review reflects on how APOE's polymorphisms impact critical aspects of AD pathology, such as the neuroinflammatory response, particularly the effect of APOE on astrocytic and microglial function and microglial dynamics, synaptic function, amyloid-β load, tau pathology, autophagy, and cell-cell communication. We discuss influential factors affecting AD pathology combined with the APOE genotype, such as sex, age, diet, physical exercise, current therapies and clinical trials in the AD field. The impact of the APOE genotype in other neurodegenerative diseases characterized by overt inflammation, e.g., alpha- synucleinopathies and Parkinson's disease, traumatic brain injury, stroke, amyotrophic lateral sclerosis, and multiple sclerosis, is also addressed. Therefore, this review gathers the most relevant findings related to the APOE genotype up to date and its implications on AD and CNS pathologies to provide a deeper understanding of the knowledge in the APOE field., Open access funding provided by Lund University. This work was supported by The Strategic Research Area MultiPark (Multidisciplinary Research in neurodegenerative diseases) at Lund University, the Swedish Alzheimer Foundation, the Swedish Brain Foundation, Crafoord Foundation, Swedish Dementia Association, G&J Kock Foundation, Olle Engkvist Foundation, the Swedish Medical Research Council, the Swedish Parkinson Foundation, the A.E. Berger Foundation, the Thurings Foundation, and the Swedish mental health foundation to T.D., M.S, A.B-S. The Royal Physiographic Society of Lund grant to R.F–C. SYNDEGEN, Marie Curie grant n°721802 to G.K.G and S.K. We also thank the Spanish Ministerio de Ciencia e Innovación/FEDER/UE/PID2021-124096OB-I00; the Spanish Junta de Andalucia/FEDER/EU P18-RT-1372 and the Spanish FEDER I + D + i-USE US-1264806 to J.L.V., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Galectin-3, a rising star in modulating microglia activation under conditions of neurodegeneration

  • García-Revilla, Juan
  • Boza-Serrano, Antonio
  • Espinosa-Oliva, Ana M.
  • Sarmiento, Manuel
  • Deierborg, Tomas
  • Ruiz, Rocío
  • Martínez de Pablos, Rocío
  • Burguillos, Miguel Ángel
  • Venero, José L.
The advent of high-throughput single-cell transcriptomic analysis of microglia has revealed different phenotypes that are inherently associated with disease conditions. A common feature of some of these activated phenotypes is the upregulation of galectin-3. Representative examples of these phenotypes include disease-associated microglia (DAM) and white-associated microglia (WAM), whose role(s) in neuroprotection/neurotoxicity is a matter of high interest in the microglia community. In this review, we summarise the main findings that demonstrate the ability of galectin-3 to interact with key pattern recognition receptors, including, among others, TLR4 and TREM2 and the importance of galectin-3 in the regulation of microglia activation. Finally, we discuss increasing evidence supporting the involvement of this lectin in the main neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, Huntington's disease, amyotrophic lateral sclerosis, multiple sclerosis, traumatic brain injury, and stroke., We thank the Spanish Ministerio de Ciencia, Innovación y Universidades/FEDER/UE RTI2018-098645-B-100, PID2019-107948RA-I00 and RYC-2017-21804; the Agencia Española de Investigación PID2021-124096OB-I00 and PID2021-126090OA-I00; the Spanish Junta de Andalucia /FEDER/EU P18-RT-1372 and the Spanish FEDER I + D + i-USE US-1264806, US-1264152 and US-1265062 from University of Seville. This work has also been supported by the Strategic Research Area MultiPark (Multidisciplinary Research focused on neurodegenerative diseases) at Lund University, the Swedish Alzheimer foundation, the Swedish Brain Foundation, the Crafoord Foundation, the Swedish Dementia Association, the G&J Kock Foundation, the Olle Engkvist Foundation, the Swedish Research Council (Project 2019-06333), the Royal Physiographic Society (42222 and 40594), the A.E. Berger Foundation, the Swedish Parkinson Foundation and the Medical Faculty at Lund University. Open access funding provided by Lund University., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

ARG1-expressing microglia show a distinct molecular signature and modulate postnatal development and function of the mouse brain

  • Stratoulias, Vassilis
  • Ruiz, Rocío
  • Kanatani, Shigeaki
  • Osman, Ahmed M.
  • Keane, Lily
  • Armengol, José Ángel
  • Rodríguez-Moreno, Antonio
  • Murgoci, Adriana-Natalia
  • García-Domínguez, Irene
  • Alonso-Bellido, Isabel María
  • González Ibáñez, Fernando
  • Picard, Katherine
  • Vázquez Cabrera, Guillermo
  • Posada-Pérez, Mercedes
  • Vernoux, Nathalie
  • Tejera, Dario
  • Grabert, Kathleen
  • Cheray, Mathilde
  • González-Rodríguez, Patricia
  • Pérez-Villegas, Eva María
  • Martínez-Gallego, Irene
  • Lastra-Romero, Alejandro
  • Brodin, David
  • Ávila-Cariño, Javier
  • Cao, Yang
  • Airavaara, Mikko
  • Uhlén, Per
  • Heneka, Michael T.
  • Tremblay, Marie-Ève
  • Blomgren, Klas
  • Venero, José L.
  • Joseph, Bertrand
Molecular diversity of microglia, the resident immune cells in the CNS, is reported. Whether microglial subsets characterized by the expression of specific proteins constitute subtypes with distinct functions has not been fully elucidated. Here we describe a microglial subtype expressing the enzyme arginase-1 (ARG1; that is, ARG1+ microglia) that is found predominantly in the basal forebrain and ventral striatum during early postnatal mouse development. ARG1+ microglia are enriched in phagocytic inclusions and exhibit a distinct molecular signature, including upregulation of genes such as Apoe, Clec7a, Igf1, Lgals3 and Mgl2, compared to ARG1- microglia. Microglial-specific knockdown of Arg1 results in deficient cholinergic innervation and impaired dendritic spine maturation in the hippocampus where cholinergic neurons project, which in turn results in impaired long-term potentiation and cognitive behavioral deficiencies in female mice. Our results expand on microglia diversity and provide insights into microglia subtype-specific functions., Open access funding provided by Karolinska Institute., This research is supported by the Swedish Research Council and the Swedish Brain Foundation (P.U. and B.J.), the Sigrid Jusélius Foundation, the Svenska Kulturfonden and Academy of Finland (33552, V.S.), the Swedish Cancer Foundation (P.U. and B.J.), the Swedish Cancer Society (K.G., P.U. and B.J.), the Karolinska Institutet Foundation (P.G.-R. and B.J.), the Mexican Council of Science and Technology (F.G.I.), the Fonds de recherche du Québec—Santé (K.P.), the Wenner-Gren Foundation (K.G.), the Åke Wibergs Stiftelse (M.C.), the Spanish Ministerio de Ciencia e Innovación/FEDER/UE PID2021-124096OB-I00 (J.L.V.), PID 2019-109569GB-100 (J.A.A.) and BFU2015-68655 (A.R.-M.), the Spanish Junta de Andalucia/FEDER/EU P18-RT-1372 and the Spanish FEDER I+D+i-USE US-1264806 (J.L.V.), the Swedish Childhood Cancer Foundation (K.B., L.K., P.U. and B.J.), the Swedish governmental grants for researchers working in healthcare (K.B.), the Canada Research Chair (Tier 2) in Neurobiology of Aging and Cognition (M.-E.T.), the TracInflam grant from ERA-NET NEURON Neuroinflammation (B.J., M.-E.T. and M.T.H.) and the Academy of Finland (V.S. and M.A.; 309489, 324177)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Galectin-3 shapes toxic alpha-synuclein strains in Parkinson’s disease

  • García-Revilla, Juan
  • Boza-Serrano, Antonio
  • Jin, Yiyun
  • Vadukul, Devkee M.
  • Soldán-Hidalgo, Jesús
  • Camprubí-Ferrer, Lluís
  • García-Cruzado, Marta
  • Martinsson, Isak
  • Klementieva, Oxana
  • Ruiz, Rocío
  • Aprile, Francesco A.
  • Deierborg, Tomas
  • Venero, José L.
© The Author(s) 2023. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/., Parkinson’s Disease (PD) is a neurodegenerative and progressive disorder characterised by intracytoplasmic inclusions called Lewy bodies (LB) and degeneration of dopaminergic neurons in the substantia nigra (SN). Aggregated α-synuclein (αSYN) is known to be the main component of the LB. It has also been reported to interact with several proteins and organelles. Galectin-3 (GAL3) is known to have a detrimental function in neurodegenerative diseases. It is a galactose-binding protein without known catalytic activity and is expressed mainly by activated microglial cells in the central nervous system (CNS). GAL3 has been previously found in the outer layer of the LB in post-mortem brains. However, the role of GAL3 in PD is yet to be elucidated. In post-mortem samples, we identified an association between GAL3 and LB in all the PD subjects studied. GAL3 was linked to less αSYN in the LB outer layer and other αSYN deposits, including pale bodies. GAL3 was also associated with disrupted lysosomes. In vitro studies demonstrate that exogenous recombinant Gal3 is internalised by neuronal cell lines and primary neurons where it interacts with endogenous αSyn fibrils. In addition, aggregation experiments show that Gal3 affects spatial propagation and the stability of pre-formed αSyn fibrils resulting in short, amorphous toxic strains. To further investigate these observations in vivo, we take advantage of WT and Gal3KO mice subjected to intranigral injection of adenovirus overexpressing human αSyn as a PD model. In line with our in vitro studies, under these conditions, genetic deletion of GAL3 leads to increased intracellular αSyn accumulation within dopaminergic neurons and remarkably preserved dopaminergic integrity and motor function. Overall, our data suggest a prominent role for GAL3 in the aggregation process of αSYN and LB formation, leading to the production of short species to the detriment of larger strains which triggers neuronal degeneration in a mouse model of PD., This work was supported by The Michael J. Fox Foundation For Parkinson's Research (Grant ID: 11902). DLB samples were kindly provided by Elisabet Englund (Lund University) and PD samples were obtained with the help of Raquel Sánchez-Valle (Hospital Clínic de Barcelona, IDIBAPS, Universitat de Barcelona). J.G-R is granted by Spanish Ministerio de Universidades/NexGenerationEU/Ayudas Margarita Salas (20117) and Swedish Demensfonden. The Strategic Research Area MultiPark (Multidisciplinary Research in neurodegenerative diseases) at Lund University, the Swedish Brain Foundation, Crafoord Foundation, Swedish Dementia Association, G&J Kock Foundation, Olle Engkvist Foundation, Gamla Tjänarinnor Foundation, the Swedish Medical Research Council, the Swedish Parkinson Foundation, the Swedish Parkinson Research Foundation the A.E. Berger Foundation, the Thurings Foundation, and the Swedish mental health foundation to T.D., I.M., and The Swedish Research Council (International postdoc, 2019-06333) to A.B-S. We also thank the Spanish Ministerio de Ciencia e Innovación/FEDER/UE/PID2021-124096OB-I00; the Spanish Junta de Andalucia/FEDER/EU P18-RT-1372, the Spanish FEDER I + D + i-USE US-1264806, and the Agencia Española de Investigación PID2021-124096OB-I00 to J.L.V, and R.R. We thank the Agencia Española de Investigación PID2021-124096OB-I00 and the Spanish Junta de Andalucia /FEDER/EU P18-RT-1372. FAA is grateful to UK Research and Innovation (Future Leaders Fellowship MR/S033947/1), Alzheimer’s Society, UK (Grant 511), and Alzheimer’s Research UK (ARUK-PG2019B-020) for the support., Open access funding provided by Lund University., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Microglial Caspase-3 is essential for modulating hippocampal neurogenesis

  • Alonso Bellido, Isabel M.
  • Posada-Pérez, Mercedes
  • Hernández-Rasco, Francisco
  • Vázquez-Reyes, Sandra
  • Cabanillas, María
  • Herrera, Antonio J.
  • Bachiller, Sara
  • Soldán-Hidalgo, Jesús
  • Espinosa-Oliva, Ana M.
  • Joseph, Bertrand
  • Pablos, Rocío M. de
  • Venero, José L.
  • Ruiz, Rocío
© 2023 The Author(s). Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/)., Adult hippocampal neurogenesis (AHN) is a process involved in numerous neurodegenerative diseases. Many researchers have described microglia as a key component in regulating the formation and migration of new neurons along the rostral migratory stream. Caspase-3 is a cysteine-aspartate-protease classically considered as one of the main effector caspases in the cell death program process. In addition to this classical function, we have identified the role of this protein as a modulator of microglial function; however, its action on neurogenic processes is unknown. The aim of the present study is to identify the role of Caspase-3 in neurogenesis-related microglial functions. To address this study, Caspase-3 conditional knockout mice in the microglia cell line were used. Using this tool, we wanted to elucidate the role of this protein in microglial function in the hippocampus, the main region in which adult neurogenesis takes place. After the reduction of Caspase-3 in microglia, mutant mice showed a reduction of microglia in the hippocampus, especially in the dentate gyrus region, a region inherently associated to neurogenesis. In addition, we found a reduction in doublecortin-positive neurons in conditional Caspase-3 knockout mice, which corresponds to a reduction in neurogenic neurons. Furthermore, using high-resolution image analysis, we also observed a reduction in the phagocytic capacity of microglia lacking Caspase-3. Behavioral analysis using object recognition and Y-maze tests showed altered memory and learning in the absence of Caspase-3. Finally, we identified specific microglia located specifically in neurogenic niche positive for Galectin 3 which colocalized with Cleaved-Caspase-3 in control mice. Taken together, these results showed the essential role of Caspase-3 in microglial function and highlight the relevant role of this specific microglial phenotype in the maintenance of AHN in the hippocampus., This work was supported by grants from the Spanish Ministerio de Ciencia e Innovación /FEDER/UE (PID2021-124096OB-I00), the Spanish Junta de Andalucia /FEDER/EU (P18-RT-1372) and VI PPIT-US (JS-H). Images were obtained in the Centro de Investigación, Tecnología e Innovación de la Universidad de Sevilla (CITIUS)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Galectin-3 is upregulated in frontotemporal dementia patients with subtype specificity

  • Borrego-Écija, Sergi
  • Pérez-Millan, Agnès
  • Antonell, Anna
  • Fort-Aznar, Laura
  • Kaya-Tilki, Elif
  • León-Halcón, Alberto
  • Lladó, Albert
  • Molina-Porcel, Laura
  • Balasa, Mircea
  • Juncà-Parella, Jordi
  • Vitorica, Javier
  • Venero, José L.
  • Deierborg, Tomas
  • Boza-Serrano, Antonio
  • Sánchez-Valle, Raquel
Neuroinflammation is a major contributor to the progression of frontotemporal dementia (FTD). Galectin-3 (Gal-3), a microglial activation regulator, holds promise as a therapeutic target and potential biomarker. Our study aimed to investigate Gal-3 levels in patients with FTD and assess its diagnostic potential., This work was supported by Instituto de Salud Carlos III, Spain (grant no. PI20/0448 to Dr R. Sanchez-Valle, Instituto de Salud Carlos III, Spain, co-funded by the EU (FEDER) “Una manera de hacer Europa” and PI19/00449 to Dr Lladó) and Generalitat de Catalunya (SGR 2021-01126). Dr S. Borrego-Écija is a recipient of the Joan Rodés Josep Baselga grant from FBBVA. Antonio Boza-Serrano, PhD is recipient of the Vetenskapsrådet grant, 2019-0633, Kungliga Fysiografiska Sällskapet i Lund, 20191114ABS and 20211129ABS, Greta och Johan Kocks stiftelser, 20201201ABS, and Juan de la Cierva Incorporación—IJC2019-040731-I. Professor Jose Luis Venero is recipient of Spanish Ministerio de Ciencia e Innovación /FEDER/UE (PID2021-124096OB-I00). Professor Javier Vitorica is recipient of Instituto de Salud Carlos III, Union PI18/01556, PI21/00914. Professor Tomas Deierborg is recipient of: Swedish Demensfonden, The Strategic Research Area MultiPark (Multidisciplinary Research in neurodegenerative diseases) at Lund University, the Swedish Brain Foundation, Crafoord Foundation, Swedish Dementia Association, G&J Kock Foundation, Olle Engkvist Foundation, Gamla Tjänarinnor Foundation, the Swedish Medical Research Council, the Swedish Parkinson Foundation, the Swedish Parkinson Research Foundation, the A.E. Berger Foundation., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Dopaminergic neurons lacking Caspase-3 avoid apoptosis but undergo necrosis after MPTP treatment inducing a Galectin-3-dependent selective microglial phagocytic response

  • García-Revilla, Juan
  • Ruiz, Rocío
  • Espinosa-Oliva, Ana M.
  • Santiago, Marti
  • García-Domínguez, Irene
  • Camprubí-Ferrer, Lluís
  • Bachiller, Sara
  • Deierborg, Tomas
  • Joseph, Bertrand
  • Pablos, Rocío M. de
  • Rodríguez-Gómez, José A.
  • Venero, José L.
Parkinson's Disease (PD) is a progressive neurodegenerative disorder characterized by the loss of dopaminergic neurons in the Substantia nigra pars compacta (SNpc). Apoptosis is thought to play a critical role in the progression of PD, and thus understanding the effects of antiapoptotic strategies is crucial for developing potential therapies. In this study, we developed a unique genetic model to selectively delete Casp3, the gene encoding the apoptotic protein caspase-3, in dopaminergic neurons (TH-C3KO) and investigated its effects in response to a subacute regime of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) administration, which is known to trigger apoptotic loss of SNpc dopaminergic neurons. We found that Casp3 deletion did not protect the dopaminergic system in the long term. Instead, we observed a switch in the cell death pathway from apoptosis in wild-type mice to necrosis in TH-C3KO mice. Notably, we did not find any evidence of necroptosis in our model or in in vitro experiments using primary dopaminergic cultures exposed to 1-methyl-4-phenylpyridinium in the presence of pan-caspase/caspase-8 inhibitors. Furthermore, we detected an exacerbated microglial response in the ventral mesencephalon of TH-C3KO mice in response to MPTP, which mimicked the microglia neurodegenerative phenotype (MGnD). Under these conditions, it was evident the presence of numerous microglial phagocytic cups wrapping around apparently viable dopaminergic cell bodies that were inherently associated with galectin-3 expression. We provide evidence that microglia exhibit phagocytic activity towards both dead and stressed viable dopaminergic neurons through a galectin-3-dependent mechanism. Overall, our findings suggest that inhibiting apoptosis is not a beneficial strategy for treating PD. Instead, targeting galectin-3 and modulating microglial response may be more promising approaches for slowing PD progression., This work was supported by the Spanish Ministerio de Ciencia e Innovación/ Agencia Española de Investigación (PID2021-124096OB-I00 and the program FORTALECE (FORT23/00008). J.G-R is granted by Demensfonden, The Royal Physiografic Society of Lund, Neurofonden, The Greta och Johan Kocks stiftelser, and Bertil och Ebon Norlins stiftelse., Open access funding provided by Lund University., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

HERC1 E3 Ubiquitin Ligase Is Necessary for Autophagy Processes and for the Maintenance and Homeostasis of Vesicles in Motor Nerve Terminals, but Not for Proteasomal Activity

  • Pérez-Castro, Miguel Ángel
  • Hernández-Rasco, Francisco
  • Alonso-Bellido, Isabel María
  • Letrán-Sánchez, María S
  • Pérez-Villegas, Eva María
  • Vitallé, Joana
  • Real, Luis Miguel
  • Ruiz-Mateos, Ezequiel
  • Venero, José Luis
  • Tabares, Lucía
  • Carrión, Ángel Manuel
  • Armengol, José Ángel
  • Bachiller, Sara
  • Ruiz, Rocío
(This article belongs to the Special Issue Molecular and Neuromuscular Mechanisms in Skeletal Muscle Aging), The ubiquitin proteasome system (UPS) is implicated in protein homeostasis. One of the proteins involved in this system is HERC1 E3 ubiquitin ligase, which was associated with several processes including the normal development and neurotransmission at the neuromuscular junction (NMJ), autophagy in projection neurons, myelination of the peripheral nervous system, among others. The tambaleante (tbl) mouse model carries the spontaneous mutation Gly483Glu substitution in the HERC1 E3 protein. Using this model, we analyzed the implication of HERC1 E3 ubiquitin ligase in the activity of UPS, autophagy, and synaptic homeostasis in brain and muscle tissues. Regarding UPS, no differences were found in its activity nor in the specific gene expression in both brain and muscle tissues from tbl compared with the control littermates. Furthermore, the use of the specific UPS inhibitor (MG-132), did not alter the evoked neurotransmitter release in the levator auris longus (LAL) muscle. Interestingly, the expression of the autophagy-related gene p62 was significantly increased in the muscle of tbl compared to the control littermates. Indeed, impaired evoked neurotransmitter release was observed with the autophagy inhibitor Wortmannin. Finally, altered levels of Clathrin and Synaptophysin were detected in muscle tissues. Altogether, our findings show that HERC1 E3 ubiquitin ligase mutation found in tbl mice alters autophagy and vesicular recycling without affecting proteasomal function., This research was funded by the Ministerio de Ciencia e Innovación (PID2021-124096OB-I00) and Junta de Andalucía, Consejería de Economía y Conocimiento (P18-RT-1372). S.B. was supported by Ramón y Cajal 2021 research grant (RYC-2021-031661-I, funded by MCIN/AEI/10.13039/501100011033 and by European Union NextGenerationEU/PRTR). J.Á.A. and E.M.P.-V. were funded by the MINECO grant PID2019-109569GB-I00., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Galectin 3: A new player in the pathogenesis of Parkinson's disease

  • García-Revilla, Juan
  • Venero, José Luis
  • Rodríguez-Gómez, José A.
Perspective., This work was supported by the Spanish Ministerio de Ciencia e Innovación/ Agencia Española de Investigación (PID2021-124096OB-I00) (to JLV). JGR was granted by Demensfonden, The Royal Physiografic Society of Lund, Neurofonden, The Greta och Johan Kocks stiftelser, and Bertil och Ebon Norlins stiftelse., Peer reviewed